Cargando…

Genetic contributions to brain serotonin transporter levels in healthy adults

The serotonin transporter (5-HTT) critically shapes serotonin neurotransmission by regulating extracellular brain serotonin levels; it remains unclear to what extent 5-HTT levels in the human brain are genetically determined. Here we applied [(11)C]DASB positron emission tomography to image brain 5-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruzzone, Silvia Elisabetta Portis, Nasser, Arafat, Aripaka, Sagar Sanjay, Spies, Marie, Ozenne, Brice, Jensen, Peter Steen, Knudsen, Gitte Moos, Frokjaer, Vibe Gedsoe, Fisher, Patrick MacDonald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542378/ https://www.ncbi.nlm.nih.gov/pubmed/37777558 http://dx.doi.org/10.1038/s41598-023-43690-x

Ejemplares similares

Common HTR2A variants and 5‐HTTLPR are not associated with human in vivo serotonin 2A receptor levels
por: Spies, Marie, et al.
Publicado: (2020)

Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
por: Armand, Sophia, et al.
Publicado: (2022)

Brain serotonin 4 receptor binding is inversely associated with verbal memory recall
por: Stenbæk, Dea S., et al.
Publicado: (2017)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
por: Dam, Vibeke Høyrup, et al.
Publicado: (2022)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2020)

Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study
por: Jensen, Kristian Høj Reveles, et al.
Publicado: (2022)

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
por: Burmester, Daniel Rødbro, et al.
Publicado: (2022)

Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study
por: Vulpius, Gunild M, et al.
Publicado: (2023)

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
por: Sankar, Anjali, et al.
Publicado: (2023)

No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
por: Stenbæk, Dea Siggaard, et al.
Publicado: (2017)

Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study
por: Hansen, Hanne Demant, et al.
Publicado: (2020)

Default mode network functional connectivity negatively associated with trait openness to experience
por: Marstrand-Joergensen, Maja Rou, et al.
Publicado: (2021)

Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
por: McCulloch, Drummond E-Wen, et al.
Publicado: (2021)

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
por: Larsen, Søren Vinther, et al.
Publicado: (2022)

Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
por: Søndergaard, Anna, et al.
Publicado: (2022)

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2022)

Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
por: McCulloch, Drummond E-Wen, et al.
Publicado: (2022)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
por: Jensen, Kristian Høj Reveles, et al.
Publicado: (2023)

Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
por: Høgsted, Emma Sofie, et al.
Publicado: (2021)

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
por: Rasmussen, Annika Læbo, et al.
Publicado: (2023)

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
por: Sankar, Anjali, et al.
Publicado: (2023)

Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females
por: Tuominen, Lauri, et al.
Publicado: (2017)

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
por: Larsen, S. V., et al.
Publicado: (2020)

BDNF val66met association with serotonin transporter binding in healthy humans
por: Fisher, P M, et al.
Publicado: (2017)

Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
por: Sundström Poromaa, Inger, et al.
Publicado: (2019)

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
por: Conradi, Juliane, et al.
Publicado: (2023)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT(2A) Receptor Density in the Pig Brain
por: Raval, Nakul Ravi, et al.
Publicado: (2021)

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
por: Jorgensen, Anders, et al.
Publicado: (2022)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
por: Jensen, Mathias Ebbesen, et al.
Publicado: (2022)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
por: Beliveau, Vincent, et al.
Publicado: (2022)

Open and Calm – A randomized controlled trial evaluating a public stress reduction program in Denmark
por: Jensen, Christian G., et al.
Publicado: (2015)

Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
por: Faurholt-Jepsen, Maria, et al.
Publicado: (2021)

Blood–brain barrier permeable β-blockers linked to lower risk of Alzheimer’s disease in hypertension
por: Beaman, Emily Eufaula, et al.
Publicado: (2022)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
por: Hjordt, Liv V., et al.
Publicado: (2020)

Brain Networks Implicated in Seasonal Affective Disorder: A Neuroimaging PET Study of the Serotonin Transporter
por: Nørgaard, Martin, et al.
Publicado: (2017)

Familial Risk for Major Depression is Associated with Lower Striatal 5-HT(4) Receptor Binding
por: Madsen, Karine, et al.
Publicado: (2014)

Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population
por: Dam, Vibeke H., et al.
Publicado: (2019)

Pharmacological sex hormone manipulation as a risk model for depression
por: Frokjaer, Vibe G.
Publicado: (2020)

Serotonin 2A receptors contribute to the regulation of risk-averse decisions
por: Macoveanu, Julian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2ikosngb7k6q75jlkdhjsqg3v9